Skip to main content

Table 5 Gastrointestinal Symptom Rating Scale Total Score

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Visit

Gas Defense

Placebo

Day 0

Screen/Rand

40.8 ± 19.8 (29)

39.4 ± 12.1 (29)

Day 14

Mid-Study

29.0 ± 8.7 (29)

31.6 ± 11.4 (29)

Day 29

End-of-Study

25.2 ± 10.0 (29)

29.4 ± 9.7 (29)

Change from

Day 0 to Day 14

-11.9 ± 16.4 (29)

-7.8 ± 11.7 (29)

Change from

Day 0 to Day 29

-15.6 ± 17.4 (29)

-9.9 ± 12.3 (29)

  1. Values are expressed as mean ± standard deviation.